Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SPHK2 inhibitors(Sphingosine kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Pseudo-Obstruction | Discovery | - | 05 Jun 2025 | |
| Colonic Pseudo-Obstruction | Discovery | - | 05 Jun 2025 | |
| Dermatomyositis | Discovery | - | 05 Jun 2025 | |
| Dermatomyositis | Discovery | - | 05 Jun 2025 | |
| Idiopathic Pulmonary Fibrosis | Discovery | - | 05 Jun 2025 | |
| Idiopathic Pulmonary Fibrosis | Discovery | - | 05 Jun 2025 | |
| Immune System Diseases | Discovery | - | 05 Jun 2025 | |
| Immune System Diseases | Discovery | - | 05 Jun 2025 | |
| Urogenital Diseases | Discovery | - | 05 Jun 2025 | |
| Urogenital Diseases | Discovery | - | 05 Jun 2025 |





